Thyroid cancer susceptibility gene detection kit
A thyroid cancer, susceptibility gene technology, applied in thyroid cancer susceptibility gene detection kits, medical and biological fields, can solve problems such as affecting tumor susceptibility and weakening base excision repair ability
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0012] Step 1: Extract the DNA template, and use a commercial kit to extract the subject's genomic DNA.
[0013] Step 2: PCR amplification reaction
[0014] Use the PCR reaction component in the detection kit, which contains the following primers:
[0015] SEQ.ID NO.1: 5'3'
[0016] SEQ.ID NO.2: 5'3'
[0017] SEQ.ID NO.3: 5'3'
[0018] SEQ.ID NO.4: 5'3'
[0019] The reaction system for PCR amplification is: 10×PCR reaction buffer 2.5ul; 2.5mM dNTP mixture 2ul, 5U / ul Taq enzyme 0.2ul, DNA template about 20ng, 10uM forward primer and reverse primer each 1ul, add deionized Water to 25ul;
[0020] The reaction conditions of PCR amplification were: denaturation and enzyme activation at 95°C for 5 minutes, denaturation at 94°C for 30 seconds, annealing at 55°C for 45 seconds, extension at 72°C for 2 minutes, 35 cycles, and finally extension at 72°C for 10 minutes.
[0021] Step 3: Purification of the PCR amplification product, using a commercial kit to purify the amplification...
Embodiment 2
[0028] Example 2. Services for genetic testing to prevent the onset of thyroid cancer
[0029] Step 1: Sampling and extracting DNA. The physician in the laboratory department of the hospital guides the subject to take samples, and uses a commercial kit for DNA extraction.
[0030] Step 2: Gene sequencing, using the kit provided by the present invention to sequence the genome DNA of the subject.
[0031] Step 3: Risk assessment for high-risk groups of thyroid cancer. Through the analysis of the subject's gene sequence, a risk assessment and analysis report of thyroid cancer susceptibility genes is issued. The kit includes the detection of SNP site information on the XRCC1 and hMSH2 genes and the results of genetic risk assessment. In addition, according to the risk level of the subject, the physician will explain and interpret the thyroid cancer susceptibility gene test report to the subject in detail.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com